Genomic characterization of inpatient evolution of MRSA resistant to daptomycin, vancomycin and ceftaroline

J Antimicrob Chemother. 2019 May 1;74(5):1452-1454. doi: 10.1093/jac/dkz003.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Ceftaroline
  • Cephalosporins / pharmacology
  • Daptomycin / pharmacology
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Evolution, Molecular*
  • Female
  • Genomics
  • Humans
  • Inpatients
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / genetics*
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification
  • Microbial Sensitivity Tests
  • Middle Aged
  • Mutation
  • Polymorphism, Single Nucleotide
  • Staphylococcal Infections / blood
  • Staphylococcal Infections / microbiology
  • Vancomycin / pharmacology

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Vancomycin
  • Daptomycin